Celltrion's New Obesity Drug Shows Promise in Preclinical Study | Retatrutide News

Celltrion's quadruple-hormone obesity drug outperformed a triple-action competitor in a mouse study. This development is significant for the future of m...
Clinical Trials · November 4, 2026